Amgen (AMGN) Net Margin (QoQ) (2009 - 2026)
Powered by 
Analysis
Amgen (AMGN) Net Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.54 Bn | 192.56 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.55 Bn | 176.37 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.10 Bn | 123.25 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.62 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.69 Bn | 55.51 Bn | 1.37 Bn |
| 6 | Moderna | 53.54 Bn | 48.40 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.10 Bn | 992.69 Mn |
| 8 | Biogen | 31.80 Bn | 30.52 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn |
| 10 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 252.00 |
| Mar 31, 2026 | 760.00 |
| Dec 31, 2025 | -2,014.00 |
| Sep 30, 2025 | 1,805.00 |
| Jun 30, 2025 | -563.00 |
| Mar 31, 2025 | 1,433.00 |
| Dec 31, 2024 | -2,638.00 |
| Sep 30, 2024 | 2,439.00 |
| Jun 30, 2024 | 1,041.00 |
| Mar 31, 2024 | -1,088.00 |
| Dec 31, 2023 | -1,570.00 |
| Sep 30, 2023 | 532.00 |
| Jun 30, 2023 | -2,680.00 |
| Mar 31, 2023 | -30,553.00 |
| Dec 31, 2022 | 31,985.00 |
| Sep 30, 2022 | 1,224.00 |
| Jun 30, 2022 | -369.00 |
| Mar 31, 2022 | -408.00 |
| Dec 31, 2021 | -36.00 |
| Sep 30, 2021 | 2,098.00 |